Research Frontiers Incorporated
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8.9% | -8.5% | -4.1% | -11.3% | +34.7% | -6.7% | -15.8% | -12.7% | -18.7% | +36.8% | -19.6% | |
| – | -8.5% | -8.0% | -3.1% | -10.6% | -3.7% | -8.2% | -21.8% | -18.1% | -29.2% | +76.3% | -27.8% | |
| – | +371.6% | -15.4% | -8.9% | -13.6% | +21.0% | -32.2% | -5.8% | -11.3% | -41.2% | +92.6% | -15.0% | |
| – | -18.1% | -15.4% | -8.9% | -13.6% | +21.0% | -32.2% | -5.8% | -11.3% | -41.2% | +92.6% | -15.0% | |
| – | +39.1% | -4.6% | +12.7% | -2.8% | -37.2% | +47.2% | -44.7% | -30.7% | +9.9% | +33.4% | -61.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -11.1% | +32.0% | -11.3% | -54.9% | +715.2% | -6.5% | +2.5% | -7.6% | +3.8% | -1.6% | +4.2% | |
| – | +5.0% | +58.4% | -11.3% | -54.9% | +52.8% | -21.7% | +33.0% | -24.3% | +40.4% | +6.1% | +30.0% | |
| – | +2.2% | +2.2% | -24.5% | -32.9% | +18.1% | +3.0% | +3.0% | +3.0% | +2.9% | +2.3% | +2.3% | |
| – | +58.5% | +236.6% | -64.4% | -43.7% | +150.2% | -84.5% | +83.1% | +19.6% | +355.3% | -23.8% | +33.7% | |
| – | -8.7% | -12.3% | -3.0% | -5.6% | -7.7% | -6.8% | -25.9% | -16.6% | -37.7% | +91.0% | -37.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.4% | +0.0% | +0.0% | +0.0% | +1.5% | +2.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.